24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Richard Francis
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:08
Can a tweet derail a $900 million cyber-tech deal?
09:32
XTEND lands $8.8M Pentagon contract for advanced AI-powered drones
09:13
AI agents as leaders of the revolution in sales
08:46
Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?
More stories
Buzz
Most popular
Daily
Weekly
1
EU approves Nvidia’s $700M acquisition of Israeli startup Run:ai
2
Israeli tech’s top 10 funding rounds of 2024: Wiz sets another record
3
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
4
Israel will "experience a 'baby boom' of innovation" in 2025, says RUNI Ventures
5
The Wiz of GenAI security? “Lasso has the potential to be a once-in-a-decade company in cyber”
More news
Richard Francis
2 stories about Richard Francis
Teva soars with double-digit growth in Q3, raises annual forecast
06.11.24
|
Sophie Shulman
Strong sales of Austedo and Ajovy push Teva’s revenues above expectations, with the company forecasting up to $16.5 billion in 2024.
Teva CEO: "The company played not to lose, now we’ll play to win"
21.02.24
|
Sophie Shulman
Richard Francis' decision to focus on innovative drugs has boosted the stock by 40% since he took office. However, the high debt is still burdensome and the realization of the potential depends on the success of developments that are still in the laboratory
Please ensure Javascript is enabled for purposes of
website accessibility